These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 3845915)
1. In vitro activity of combinations of antibiotics against Staphylococcus aureus resistant to gentamicin and methicillin. Dixson S; Brumfitt W; Hamilton-Miller JM Infection; 1985; 13(1):35-8. PubMed ID: 3845915 [TBL] [Abstract][Full Text] [Related]
2. The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus. Moorhouse EC; Mulvihill TE; Jones L; Mooney D; Falkiner FR; Keane CT J Antimicrob Chemother; 1985 Mar; 15(3):291-5. PubMed ID: 3158632 [TBL] [Abstract][Full Text] [Related]
3. Gentamicin- and methicillin-resistant Staphylococcus aureus: in vitro susceptibility to antimicrobial drugs. Traub WH; Spohr M; Bauer D Chemotherapy; 1987; 33(5):361-75. PubMed ID: 3665635 [TBL] [Abstract][Full Text] [Related]
4. Novobiocin and rifampicin in combination against methicillin-resistant Staphylococcus aureus: an in-vitro comparison with vancomycin plus rifampicin. Walsh TJ; Auger F; Tatem BA; Hansen SL; Standiford HC J Antimicrob Chemother; 1986 Jan; 17(1):75-82. PubMed ID: 3633267 [TBL] [Abstract][Full Text] [Related]
5. World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. Maple PA; Hamilton-Miller JM; Brumfitt W Lancet; 1989 Mar; 1(8637):537-40. PubMed ID: 2564067 [TBL] [Abstract][Full Text] [Related]
6. Gentamicin- and methicillin-resistant, clinical isolates of Staphylococcus aureus: comparative in vitro and in vivo efficacy of alternative antimicrobial drugs. Traub WH; Spohr M; Bauer D Chemotherapy; 1984; 30(2):102-12. PubMed ID: 6559664 [TBL] [Abstract][Full Text] [Related]
7. Microbiological indications for the treatment of Staphylococcus aureus infections. Fabbri A; Tacchella A; Belli ML; Losurdo G Chemioterapia; 1988 Dec; 7(6):378-81. PubMed ID: 3219748 [TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Hong Kong isolates of methicillin-resistant Staphylococcus aureus to antimicrobial agents. French GL; Ling J; Ling T; Hui YW J Antimicrob Chemother; 1988 May; 21(5):581-8. PubMed ID: 3391861 [TBL] [Abstract][Full Text] [Related]
9. Differences in ability of cell-wall antibiotics to suppress emergence of rifampicin resistance in Staphylococcus aureus. Eng RH; Smith SM; Buccini FJ; Cherubin CE J Antimicrob Chemother; 1985 Feb; 15(2):201-7. PubMed ID: 3845078 [TBL] [Abstract][Full Text] [Related]
10. In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus. Foldes M; Munro R; Sorrell TC; Shanker S; Toohey M J Antimicrob Chemother; 1983 Jan; 11(1):21-6. PubMed ID: 6826485 [TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus. You I; Kariyama R; Zervos MJ; Kumon H; Chow JW Diagn Microbiol Infect Dis; 2000 Jan; 36(1):37-41. PubMed ID: 10744365 [TBL] [Abstract][Full Text] [Related]
12. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods. Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of six antibiotics against multiresistant staphylococci and other gram-positive cocci. Dixson S; Brumfitt W; Hamilton-Miller JM Eur J Clin Microbiol; 1985 Feb; 4(1):19-23. PubMed ID: 3157567 [TBL] [Abstract][Full Text] [Related]
15. In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus. Drugeon HB; Caillon J; Juvin ME J Antimicrob Chemother; 1994 Dec; 34(6):899-907. PubMed ID: 7730233 [TBL] [Abstract][Full Text] [Related]
16. In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus. Guenthner SH; Wenzel RP Antimicrob Agents Chemother; 1984 Aug; 26(2):268-9. PubMed ID: 6237606 [TBL] [Abstract][Full Text] [Related]
17. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method. Thamlikitkul V J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906 [TBL] [Abstract][Full Text] [Related]
18. Probable chromosomal mutation to resistance to all aminoglycosides in Staphylococcus aureus selected by the therapeutic use of gentamicin: a preliminary report. Heritage J; Settle JA; Lalani EN; Lacey RW J Antimicrob Chemother; 1986 May; 17(5):571-4. PubMed ID: 3636322 [TBL] [Abstract][Full Text] [Related]
19. Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains. Watanakunakorn C; Tisone JC Antimicrob Agents Chemother; 1982 Nov; 22(5):903-5. PubMed ID: 6924825 [TBL] [Abstract][Full Text] [Related]
20. Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. O'Neill AJ; Cove JH; Chopra I J Antimicrob Chemother; 2001 May; 47(5):647-50. PubMed ID: 11328777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]